| （単位：千ドル） | 3Q21 | 1Q22 | 2Q22 | 3Q22 | 1Q23 | 2Q23 | 3Q23 | 1Q24 | 2Q24 | 3Q24 | 1Q25 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 研究開発費 | 5,484 | 9,645 | 12,047 | 10,915 | 10,408 | 12,162 | 19,271 | 17,203 | 17,997 | 22,697 | 24,964 |
| 販売管理費 | - | - | - | - | - | 0 | 0 | - | - | - | - |
| 営業費用 | 6,638 | 14,834 | 15,428 | 13,645 | 14,334 | 16,014 | 23,963 | 22,322 | 23,532 | 28,604 | 31,850 |
| 営業利益 | -6,638 | -14,834 | -15,428 | -13,645 | -14,334 | -16,014 | -23,963 | -22,322 | -23,532 | -28,604 | -31,850 |
| 純利益 | -6,643 | -14,826 | -15,095 | -12,509 | -11,880 | -13,272 | -21,152 | -18,192 | -18,702 | -24,016 | -28,147 |
| 一株あたり利益 | - | - | -0.36 | -0.3 | -0.28 | -0.31 | -0.49 | -0.35 | -0.32 | -0.41 | -0.47 |
| 希薄化後一株あたり利益 | - | - | -0.36 | -0.3 | -0.28 | -0.31 | -0.49 | -0.35 | -0.32 | -0.41 | -0.47 |
| EBITDA | - | - | - | - | - | - | - | - | - |